Hentapan, Krizza M.
HRN: 09-19-39 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/25/2026
CEFUROXIME 750MG (VIAL)
06/25/2026
07/02/2026
IV
750mg
Q8H
UTI
Checking Initial Appropriateness